Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB

Chest

Volumn 143, Issue 6, 2013, Pages 1725-1732

  Chien, Jung Yien ^a,b   Chen, Yi Ting ^c   Shu, Chin Chung ^b   Lee, Jen Jyh ^c,d   Wang, Jann Yuan ^b   Yu, Chong Jen ^b   Yang, Pan Chyr ^b  

^a Chest Hospital   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NON MULTIDRUG RESISTANT TUBERCULOSIS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELAPSE; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR; TAIWAN; TREATMENT DURATION;

EID: 84878595292     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2051     Document Type: Article

References (27)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282(7):677-686.
2. World Health Organization. Stop TB Initiative (World Health Organization). Treatment of Tuberculosis: Guidelines. 4th ed. Geneva, Switzerland: World Health Organization;2010.
3. Kim TC, Blackman RS, Heatwole KM, Kim T, Rochester DF. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment. Am Rev Respir Dis. 1984;129(2):264-268.
4. Huang CT, Tsai YJ, Shu CC, et al Tami Group. Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients. Respir Med. 2009;103(10):1484-1491.
5. Vidal R, Martin-Casabona N, Juan A, Falgueras T, Miravitlles M. Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest. 1996;109(6):1562-1565.
6. Al-Moamary MS, Black W, Bessuille E, Elwood RK, Vedal S. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest. 1999;116(3):726-731.
7. Holtz TH, Sternberg M, Kammerer S, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006;144(9):650-659.
8. Hsu CB, Lo HY, Lee CY, et al. Preliminary evaluation of Taiwan's Tuberculosis DOTS Strategy. Taiwan Epidemiology Bulletin. 2008;24(3):54.
9. van den Berg JW, Kerstjens H, Postma D, van der Bij W, Koëter G. Sputum induction in research: beware of the beast. Am J Respir Crit Care Med. 2003;168(10):1253.
10. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 pt 1):1376-1395.
11. Murray PR, Baron EJ. Manual of Clinical Microbiology. 9th ed. Washington, D.C.: ASM Press;2007.
12. Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005;25(3):564-569.
13. Jou R, Chiang CY, Yu CY, Wu MH. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan. Int J Tuberc Lung Dis. 2009;13(9):1142-1147.
14. Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis. 1971;103(5):625-640.
15. Hsueh PR, Liu YC, So J, Liu CY, Yang PC, Luh KT. Mycobacterium tuberculosis in Taiwan. J Infect. 2006;52(2):77-85.
16. Blumberg HM, Burman WJ, Chaisson RE, et al; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603-662.
17. Koh WJ, Yu CM, Suh GY, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis. 2006;10(9):1001-1007.
18. Wang JY, Lee LN, Lai HC, et al. Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis. 2007;196(2):281-288.
19. Mount FW, Ferebee SH. United States Public Health service cooperative investigation of antimicrobial therapy of tuberculosis, V. Report on thirty-two-week observations on combinations of isoniazid, streptomycin, and para-aminosalicylic acid. Am Rev Tuberc. 1954;70(3):521-526.
20. Yajko DM, Nassos PS, Sanders CA, Madej JJ, Hadley WK. High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis. 1994;19(2):334-336.
21. Jeon K, Koh WJ, Kwon OJ, et al. Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea. Int J Tuberc Lung Dis. 2005;9(9):1046-1051.
22. Peterson EM, Nakasone A, Platon-DeLeon JM, Jang Y, de La Maza LM, Desmond E. Comparison of direct and concentrated acid-fast smears to identify specimens culture positive for Mycobacterium spp. J Clin Microbiol. 1999;37(11):3564- 3568.
23. Newman R, Doster BE, Murray FJ, Woolpert SF. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial. Am Rev Respir Dis. 1974;109(2):216-232.
24. Bonilla CA, Crossa A, Jave HO, et al. Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS ONE. 2008;3(8): e2957.
25. Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A, et al. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Int J Tuberc Lung Dis. 2002;6(10):909-912.
26. Lee JS, Kim EC, Joo SI, et al. The incidence and clinical implication of sputum with positive acid-fast bacilli smear but negative in mycobacterial culture in a tertiary referral hospital in South Korea. J Korean Med Sci. 2008;23(5):767-771.
27. Steingart KR, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(10):664-674.